In some areas of the world, a lack of infrastructure or test costs may be significant barriers to adopting new rapid AST technologies.
← all excerpts
What's old is new: leveraging existing antimicrobial susceptibility test methods for rapid results in patients with bloodstream infections.
1
—
—